VRCA

0.42

4.20% -0.0184

After Hours: .41 -0.01 -2.38%

Verrica Pharmaceuticals Inc (VRCA)

Overview News Price History Option Chain Financials Discussions Forecast

Verrica Pharmaceuticals Inc stock is traded at $0.42, with a volume of 357.12K. It is down -4.20% in the last 24 hours and down -34.39% over the past month.

Previous Close:

$0.4384

Open:

$0.4178

24h Volume:

357.12K

Relative Volume:

0.90

Market Cap:

$38.55M

Revenue:

$5.12M

Net Income/Loss:

$-67.00M

P/E Ratio:

-0.2857

EPS:

-1.47

Net Cash Flow:

$-38.94M

1W Performance:

-4.00%

1M Performance:

-34.39%

6M Performance:

-71.03%

1Y Performance:

-93.18%

1-Day Range:

$0.3816

$0.4288

1-Week Range:

$0.3816

$0.4698

52-Week Range:

$0.3816

$11.41

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name

Verrica Pharmaceuticals Inc

Sector

Healthcare (1182)

Industry

Biotechnology (678)

Phone

484-453-3300

Address

10 NORTH HIGH STREET, WEST CHESTER, PA

Employee

Twitter

Next Earnings Date

2025-03-11

Latest SEC Filings

VRCA's Discussions on Twitter

Compare VRCA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VRCA Verrica Pharmaceuticals Inc	0.42	38.55M	5.12M	-67.00M	-38.94M	-1.47
VRTX Vertex Pharmaceuticals Inc	484.01	124.29B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	610.64	68.39B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	590.06	35.99B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	262.16	33.93B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	264.32	28.47B	3.81B	-644.79M	-669.77M	-6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-06-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-25-23	Upgrade	Needham	Hold → Buy
Mar-22-23	Initiated	Jefferies	Buy
Feb-13-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
May-25-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
May-14-21	Initiated	RBC Capital Mkts	Outperform
Dec-24-20	Reiterated	H.C. Wainwright	Buy
Jul-15-20	Downgrade	BofA Securities	Buy → Neutral
Jun-30-20	Reiterated	H.C. Wainwright	Buy
Jun-24-20	Initiated	Northland Capital	Outperform
Mar-24-20	Initiated	Needham	Buy
Feb-21-19	Initiated	H.C. Wainwright	Buy

View All

Verrica Pharmaceuticals Inc Stock (VRCA) Latest News

Apr 02, 2025

Verrica Pharmaceuticals appoints new board member By Investing.com - Investing.com South Africa

Apr 02, 2025

Verrica Pharmaceuticals expands board with new director By Investing.com - Investing.com Canada

Apr 02, 2025

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - The Manila Times

Apr 02, 2025

Strategic Move: Verrica Adds Formation Bio CDO to Board Amid YCANTH Success - Stock Titan

Apr 02, 2025

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MyChesCo

Apr 02, 2025

Apr 01, 2025

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - MSN

Apr 01, 2025

Harmony, Lungpacer, Verrica and Arbutus make C-suite hires - The Business Journals

Apr 01, 2025

Mar 31, 2025

Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025

Exclusive: Verrica Pharmaceuticals CEO Fireside Chat at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 30, 2025

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer - MSN

Mar 30, 2025

Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments By Investing.com - Investing.com South Africa

Mar 26, 2025

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer - GlobeNewswire

Mar 26, 2025

Verrica Pharmaceuticals appoints Rosenberg as CMO - MSN

Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments - Investing.com

Mar 26, 2025

Dermatology Drug Pioneer Joins Verrica to Accelerate YCANTH Growth - Stock Titan

Mar 26, 2025

Mar 19, 2025